Quotes Decoy Therapeutics Inc. London S.E.

Stocks

End-of-day quote London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

08-13	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Stock exchange

London S.E.- p -.--% 0 p

Markets		Price	Change	Volumes
Nasdaq	DCOY	2.690USD	-6.60%	72.3K $
CBOE	DCOY	2.900USD	-3.65%	452.4 $

markets

Capital turnover ratio

Float rotation

Market Cap (GBX)

1,886,932

Market Cap (USD)

1,886,932

Net sales (USD)

Number of employees

Sales / Employee (USD)

Free-Float

99.52 %

Free-Float capitalization (GBX)

1,877,967

Free-Float capitalization (USD)

1,877,967

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DECOY THERAPEUTICS INC.	-.--%	-.--%	-	-	1.89M
WUXI APPTEC CO., LTD.	-1.79%	-3.82%	+38.74%	+91.90%	69.02B
ARGENX SE	-2.06%	-1.52%	+46.40%	+86.87%	66.32B
INSMED INCORPORATED	-0.36%	+6.66%	-11.30%	+379.45%	27.66B
BIONTECH SE	+0.81%	+1.52%	+0.13%	-15.06%	25.84B
WUXI BIOLOGICS (CAYMAN) INC.	-3.00%	-2.61%	+34.45%	+11.39%	26.54B
GENMAB A/S	-1.46%	-0.09%	+24.64%	-18.36%	20.4B
PHARMAESSENTIA CORPORATION	-2.96%	-16.03%	+213.13%	+375.00%	17.63B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.49%	-6.69%	-4.69%	+539.74%	15.15B
EXELIXIS, INC.	-0.19%	+8.36%	+57.84%	+164.93%	14.65B
Average	-1.25%	-0.66%	+44.37%	+179.54%	28.32B
Weighted average by Cap.	-1.53%	-0.45%	+40.23%	+138.92%